SEARLE & CO. – Trademark Portfolio
Entity Type: 03
SEARLE & CO. holds 31 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 27 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 5 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include FLAGYL, CYTOTEC, LOMOTIL, THEO-24, and ALDACTAZIDE. The owner is based in CAGUAS, PR.
NO. 99 JARDINES STREET
CAGUAS, PR 00735
Showing of trademarks Trademarks
Trademark Classifications
SEARLE & CO.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does SEARLE & CO. have?
SEARLE & CO. has 31 U.S. trademarks filed with the USPTO. Of these, 5 registered, 2 abandoned, 24 cancelled.
What trademark classes does SEARLE & CO. file in?
SEARLE & CO. files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 21 (Housewares), Class 10 (Medical Apparatus), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are SEARLE & CO.'s most well-known trademarks?
SEARLE & CO.'s registered trademark portfolio includes well-known marks such as FLAGYL, CYTOTEC, LOMOTIL, THEO-24, and ALDACTAZIDE. These are among 5 currently registered trademarks in the portfolio.
What is SEARLE & CO.'s trademark registration success rate?
SEARLE & CO. has a 16% trademark registration rate, with 5 out of 31 resolved applications resulting in successful registration. Currently, 0 applications are pending review.